Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masaaki Niino

Showing results (1-10 of 125) with videos related to

Pageof 13
Sort By:
Drugs of Today (Barcelona, Spain : 1998)|May 27, 2010
Vitamin D and its immunoregulatory role in multiple sclerosisMasaaki Niino
Brain and Nerve = Shinkei Kenkyu No Shinpo|May 19, 2022
[Therapeutic Strategy for Multiple Sclerosis Resistant to Standard Treatment: MS Cases When Relapses Cannot be Controlled with Standard Treatment]Masaaki Niino
Mini Reviews in Medicinal Chemistry|November 30, 2007
Peroxisome proliferator-activated receptor agonists as potential therapeutic agents in multiple sclerosisMasaaki Niino
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 20, 2013
[Recent prognosis on etiology and pathophysiology of multiple sclerosis]Masaaki Niino
Journal of Neurology, Neurosurgery, and Psychiatry|December 15, 2010
Vitamin D metabolites and multiple sclerosisMasaaki Niino
Rinsho Shinkeigaku = Clinical Neurology|February 10, 2009
[Approach to find new therapies for MS from clinical view]Masaaki Niino
Expert Review of Clinical Immunology|September 21, 2012
Multiple sclerosis treatment: current best practiceMasaaki Niino
Journal of Neurology, Neurosurgery, and Psychiatry|August 22, 2012
Risk factors for multiple sclerosis: decreased vitamin D level and remote Epstein-Barr virus infection in the pre-clinical phase of multiple sclerosisMasaaki Niino
Brain and Nerve = Shinkei Kenkyu No Shinpo|December 5, 2012
[An update on the treatment options for multiple sclerosis]Masaaki Niino
Rinsho Shinkeigaku = Clinical Neurology|December 1, 2012
[Selection and optimization of therapy for progressive type multiple sclerosis]Masaaki Niino
Pageof 13

Showing results (1-10 of 125) with videos related to

Sort By:
Pageof 13
Drugs of Today (Barcelona, Spain : 1998)|May 27, 2010
Vitamin D and its immunoregulatory role in multiple sclerosisMasaaki Niino
Brain and Nerve = Shinkei Kenkyu No Shinpo|May 19, 2022
[Therapeutic Strategy for Multiple Sclerosis Resistant to Standard Treatment: MS Cases When Relapses Cannot be Controlled with Standard Treatment]Masaaki Niino
Mini Reviews in Medicinal Chemistry|November 30, 2007
Peroxisome proliferator-activated receptor agonists as potential therapeutic agents in multiple sclerosisMasaaki Niino
Nihon Rinsho. Japanese Journal of Clinical Medicine|June 20, 2013
[Recent prognosis on etiology and pathophysiology of multiple sclerosis]Masaaki Niino
Journal of Neurology, Neurosurgery, and Psychiatry|December 15, 2010
Vitamin D metabolites and multiple sclerosisMasaaki Niino
Rinsho Shinkeigaku = Clinical Neurology|February 10, 2009
[Approach to find new therapies for MS from clinical view]Masaaki Niino
Expert Review of Clinical Immunology|September 21, 2012
Multiple sclerosis treatment: current best practiceMasaaki Niino
Journal of Neurology, Neurosurgery, and Psychiatry|August 22, 2012
Risk factors for multiple sclerosis: decreased vitamin D level and remote Epstein-Barr virus infection in the pre-clinical phase of multiple sclerosisMasaaki Niino
Brain and Nerve = Shinkei Kenkyu No Shinpo|December 5, 2012
[An update on the treatment options for multiple sclerosis]Masaaki Niino
Rinsho Shinkeigaku = Clinical Neurology|December 1, 2012
[Selection and optimization of therapy for progressive type multiple sclerosis]Masaaki Niino
Pageof 13